NovaBay Pharmaceuticals, Inc. (NBY)

2.94 +0.13 (+4.63%) USD  |  NYAM  |  Dec 12, 14:43
More

NovaBay Pharmaceuticals Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for NBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Oragenics, Inc. Upgrade
NanoViricides, Inc. Upgrade
Actinium Pharmaceuticals, Inc. Upgrade